Scientists have found blood protein signals that may flag multiple sclerosis up to seven years before symptoms begin.

Learn about multiple sclerosis, its symptoms, causes, and treatment options. Understand how early diagnosis helps in managing ...

A major UK-wide study led by researchers based in Liverpool has revealed the profound impact of multiple sclerosis (MS) on ...

Hollywood actress Selma Blair's experience highlights how doctors dismissed her crippling pain and fatigue for years, a ...

Dr. Barilero brings over 30 years of global regulatory leadership across CNS, neuropsychiatry, immuno-oncology, and rare diseases, with a proven track record in guiding Phase II–III programs, securing ...

Introduction Previous trauma and adverse life experiences have been hypothesised to be aetiological factors for functional neurological disorder (FND) leading to the hypothesis of a ‘trauma-subtype’ ...

Researchers have traced the earliest stages of multiple sclerosis (MS), showing that the immune system begins attacking the brain up to seven years before diagnosis.

Retinal inner layer thinning detected by OCT offers a promising biomarker for monitoring multiple sclerosis progression.

Around 2.8 million people live with MS worldwide with an average prevalence of 36 per 100,000 people. In Europe the average prevalence is even higher (133 per 100,000), with 300 per 100,000 in Germany ...

Multiple sclerosis (MS) is a chronic autoimmune disease affecting more than 2.9 million people worldwide. It occurs when the immune system mistakenly attacks the myelin sheath, the protective ...